Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital
- PMID: 30616612
- PMCID: PMC6323702
- DOI: 10.1186/s12877-018-1008-8
Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital
Abstract
Background: Procalcitonin (PCT) is a useful marker for pneumonia. However, its clinical usefulness in elderly patients has not been studied extensively. This study aimed to assess the relationship between PCT and prognosis and pneumonia severity in elderly patients with pneumonia acquired outside the hospital.
Methods: Data considered relevant to pneumonia severity and prognosis were retrospectively obtained from clinical charts of all patients with pneumonia who were admitted to our hospital from 2010 to 2017. The primary outcome was 30-day mortality in elderly patients (aged ≥75 years), and the relationship between PCT levels and pneumonia severity, as determined by the pneumonia severity index (PSI) was also examined.
Results: Data were collected from 667 patients, of which 436 were elderly patients. Multivariate and receiver operating characteristic curve analysis revealed that albumin, body mass index, and PSI class rather than PCT are important factors related to 30-day mortality in elderly patients. PCT was also not an independent prognostic factor in younger patients. PCT levels significantly differed by pneumonia severity (mild, moderate, and severe) in both younger (p < 0.001) and elderly (p < 0.0001) patients, with levels increasing as severity increased. In contrast, C-reactive protein (CRP) levels and white blood cell counts did not significantly differ by pneumonia severity in younger and elderly patients. A subgroup analysis focused on Streptococcus pneumoniae pneumonia revealed that PCT levels differed by severity in elderly patients (p = 0.03), with levels increasing as severity increased.
Conclusion: PCT was not an independent predictor of 30-day mortality in both of elderly and younger patients. PCT levels, but not CRP levels, significantly increased with increasing pneumonia severity in younger and elderly patients, although the degree of increase tended to be lower in elderly patients compared to younger patients for the same severity. PCT levels also significantly increased with increasing pneumonia severity in elderly patients with Streptococcus pneumoniae pneumonia.
Keywords: C-reactive protein; Elderly; Pneumonia; Pneumonia severity; Procalcitonin; Prognosis.
Conflict of interest statement
Ethics approval and consent to participate
This study was performed in accordance with the Declaration of Helsinki. This human study was approved by the Fukuoka University Medical Ethics Review Board (approval: R17–042). The review board exempted the acquisition of informed consent from patients included in the study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures




Similar articles
-
The usefulness of serum procalcitonin, C-reactive protein, soluble triggering receptor expressed on myeloid cells 1 and Clinical Pulmonary Infection Score for evaluation of severity and prognosis of community-acquired pneumonia in elderly patients.Arch Gerontol Geriatr. 2019 Jan-Feb;80:53-57. doi: 10.1016/j.archger.2018.10.005. Epub 2018 Oct 12. Arch Gerontol Geriatr. 2019. PMID: 30366226
-
The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study.Int J Infect Dis. 2020 Mar;92:228-233. doi: 10.1016/j.ijid.2020.01.018. Epub 2020 Jan 22. Int J Infect Dis. 2020. PMID: 31981766
-
Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.Am J Emerg Med. 2018 Dec;36(12):2155-2160. doi: 10.1016/j.ajem.2018.03.050. Epub 2018 Mar 21. Am J Emerg Med. 2018. PMID: 29691103
-
Utility of C-reactive protein and procalcitonin in community-acquired pneumonia in children: a narrative review.Curr Med Res Opin. 2024 Dec;40(12):2191-2200. doi: 10.1080/03007995.2024.2425383. Epub 2024 Nov 5. Curr Med Res Opin. 2024. PMID: 39494704 Review.
-
The prognostic value of serum procalcitonin measurements in critically injured patients: a systematic review.Crit Care. 2019 Dec 3;23(1):390. doi: 10.1186/s13054-019-2669-1. Crit Care. 2019. PMID: 31796098 Free PMC article.
Cited by
-
Cold-inducible RNA-binding protein might determine the severity and the presences of major/minor criteria for severe community-acquired pneumonia and best predicted mortality.Respir Res. 2020 Jul 20;21(1):192. doi: 10.1186/s12931-020-01457-2. Respir Res. 2020. PMID: 32689999 Free PMC article.
-
Prognosis prediction of procalcitonin within 24 h for acute diquat poisoning.BMC Emerg Med. 2024 Apr 14;24(1):61. doi: 10.1186/s12873-024-00975-2. BMC Emerg Med. 2024. PMID: 38616281 Free PMC article.
-
Risk for prolonged hospitalization and mortality in aged community acquired pneumonia patients: a retrospective study in Japan.J Clin Biochem Nutr. 2020 Nov;67(3):302-306. doi: 10.3164/jcbn.20-85. Epub 2020 Jul 31. J Clin Biochem Nutr. 2020. PMID: 33293772 Free PMC article.
-
Procalcitonin, C-reactive protein, and white blood cell count levels in end-stage cancer patients: A retrospective study on inflammatory markers and their prognostic value.Medicine (Baltimore). 2024 Dec 6;103(49):e40792. doi: 10.1097/MD.0000000000040792. Medicine (Baltimore). 2024. PMID: 39654236 Free PMC article.
-
Evaluation of the factors affecting long-term mortality in geriatric patients followed up in intensive care unit due to hospital-acquired pneumonia.Medicine (Baltimore). 2022 Sep 23;101(38):e30645. doi: 10.1097/MD.0000000000030645. Medicine (Baltimore). 2022. PMID: 36197164 Free PMC article.
References
-
- Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America / American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27–S72. doi: 10.1086/511159. - DOI - PMC - PubMed
-
- Limper M, de Kruif MD, Duits AJ, Brandjes DPM, van Gorp ECM. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Inf Secur. 2010;60:409–416. - PubMed
-
- Kolditz M, Halank M, Schulte-Hubbert B, Hӧffken G. Procalcitonin improves the differentiation between infectious and cryptogenic / secondary organizing pneumonia. J Inf Secur. 2012;64:122–124. - PubMed
-
- Takeda S, Nagata N, Miyazaki H, Akagi T, Harada T, Kodama S, et al. Clinical utility of procalcitonin for differentiating between cryptogenic organizing pneumonia and community-acquired pneumonia. Int J Clin Med. 2015;6:372–376. doi: 10.4236/ijcm.2015.66048. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous